EDGAR Filing Documents for 0001279569-09-000539

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-09-000539

Filing Date

2009-04-20

Accepted

2009-04-20 12:36:32

Documents

Period of Report

2009-02-28

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	lorus6k.htm	6-K	18102
2	NEWS RELEASE DATED APRIL 13, 2009	ex991.htm	EX-99.1	120875
3	Q3 INTERIM FINANCIAL STATEMENTS	ex992.htm	EX-99.2	724265
4	Q3 MANAGEMENT DISCUSSION AND ANALYSIS	ex993.htm	EX-99.3	299759
5	CEO AND CFO CERTIFICATIONS	ex994.htm	EX-99.4	45337
6	LOGO	logo.jpg	GRAPHIC	14436
	Complete submission text file	0001279569-09-000539.txt		1229987

Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7

Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7

LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 09758555
SIC: 2836 Biological Products, (No Diagnostic Substances)